Clinical Trials Browser

Phase 2 × Neuroectodermal Tumors, Primitive, Peripheral × Thiotepa × Clear all

NCT04530487 2025-06-29

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

Phase 2 Terminated

1 enrolled 7 charts

Neuroblastoma, Rhabdomyosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Neurofibrosarcoma, Desmoplastic Small Round Cell Tumor

NCT00357396 2015-11-25

Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors

Phase 2 Completed

10 enrolled 7 charts

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral